Webinar: The future of Diabetic Neuropathy Management - May, 28th
Filter to find what you are looking for
Article

Safely Prescribing GLP-1 Medications for Older Adults: Remote care solutions that offer protection and connection

Remote care solutions, like connected devices and remote patient monitoring allow for safer GLP-1 use in older adults....
Article

Neuropathy and DFU Prevention to be Highlighted at the ADA’s 84th Scientific Sessions

When the world’s leading clinicians and researchers gather later this month in Orlando, Florida at ADA’s 84th Scientific Sessions, diabetic...
Article

Culturally-Sensitive Nutrition Education Studied for Pre-Diabetic African American Patients

Withings remote patient monitoring devices will be used by The Strelitz Diabetes Center at Eastern Virginia Medical School (EVMS) and...
Article

LifeMD Partners with Withings to Transform GLP-1 Weight Management Care  

LifeMD becomes the first virtual primary care provider to employ the advanced technology of Withings Rx-based, at-home Body Pro 2...
Article

The ADA and Withings Join Forces to Reduce Diabetes Risk and Complications

Peer-reviewed studies have shown that only a fraction of people with diabetes comply with the American Diabetes Association (ADA) standard...
Article

Small Fiber Neuropathy – The Under-Diagnosed Peripheral Neuropathy

In an interview with Harvard Medical School’s Harvard Health, Dr. Khosro Farhad, a neuropathy expert at Harvard-affiliated Massachusetts General Hospital,...
Article

Understanding our ESC Technology for Detecting and Monitoring DPN

Electrochemical Skin Conductance (ESC) is a physiological parameter that measures the reactivity of sweat glands and small nerve fibers in...
Article

Withings Introduces Body Pro 2, an Rx Device for Early Detection of DPN*

Smart Scales have traditionally been used by consumers to track their personal wellness metrics. However, Withings saw an opportunity to...
Article

Part 3: Supporting Safe and Sustainable Weight Loss With GLP-1s – Managing weight after medication

Weight gain is likely when patients stop taking a GLP-1 therapy. A 2022 study found patients who took the GLP-1...